Your browser doesn't support javascript.
COVID-19 mass vaccination - an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns.
Roseline, Mazet; Luc, Choisnard; Julien, Leenhardt; Olivier, Epaulard; Etienne, Brudieu; Pierrick, Bedouch.
  • Roseline M; Pharmacy Unit, Grenoble University Hospital, Grenoble, France.
  • Luc C; University Grenoble Alpes DPM, Saint Martin d'Hères, France.
  • Julien L; Pharmacy Unit, Grenoble University Hospital, Grenoble, France.
  • Olivier E; Infectious Diseases Department, Grenoble University Hospital, Grenoble, France.
  • Etienne B; Groupe de recherche en infectiologie clinique, University Grenoble Alpes, Grenoble, France.
  • Pierrick B; Pharmacy Unit, Grenoble University Hospital, Grenoble, France.
Emerg Microbes Infect ; 11(1): 804-806, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: covidwho-1713525
ABSTRACT
In order to optimise the operational implementation of mass vaccination policies, it is critical to consider not only the supply of vaccines as well as each element of the vaccination process. This study, which was conducted in a vaccination center clearly shows how the choice of a syringe reference used during the COVID-19 vaccination campaign influences the number of vaccine doses available. The results appear to be closely related to the type of vaccine used (COMIRNATY® and SPIKEVAX®). In this context, the choice of the right reference of syringe has major economic and organisational consequences on a global scale.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Estudio experimental Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Artículo País de afiliación: 22221751.2022.2048968

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Estudio experimental Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Artículo País de afiliación: 22221751.2022.2048968